{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:35:26Z","timestamp":1785479726942,"version":"3.56.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.abb.2024.110161","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:39:41Z","timestamp":1726933181000},"page":"110161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications"],"prefix":"10.1016","volume":"761","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.abb.2024.110161_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.abb.2024.110161_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119674","article-title":"Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model","volume":"279","author":"Khater","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.abb.2024.110161_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12272-021-01343-5","article-title":"Aldose Reductase: a cause and a potential target for the treatment of diabetic complications","volume":"44","author":"Thakur","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.abb.2024.110161_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.abb.2015.02.004","article-title":"Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy","volume":"572","author":"Gong","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2024.110161_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129446","article-title":"An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives","volume":"1224","author":"Sever","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.abb.2024.110161_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139207","article-title":"Selectivity challenges for aldose reductase inhibitors: a review on comparative SAR and interaction studies","volume":"1318","author":"Kumari","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biom12040485","article-title":"In search of differential inhibitors of aldose reductase","volume":"12","author":"Balestri","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.abb.2024.110161_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200043","article-title":"Identification of 9H-purin-6-amine derivatives as novel aldose reductase inhibitors for the treatment of diabetic complications","volume":"355","author":"Zhu","year":"2022","journal-title":"Arch. Pharmazie"},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.abb.2024.110161_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103195","article-title":"Inhibition effects of quinones on aldose reductase: antidiabetic properties","volume":"70","author":"Demir","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.abb.2024.110161_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2012.00087","article-title":"Aldose reductase, oxidative stress, and diabetic mellitus","volume":"3","author":"Tang","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/abbi.1997.9882","article-title":"Sorbitol dehydrogenase from bovine lens: purification and properties","volume":"340","author":"Marini","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.abb.2024.110161_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.abb.2024.110161_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cbi.2014.10.007","article-title":"Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells","volume":"234","author":"Chang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2024.110161_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108207","article-title":"Role of sorbitol-mediated cellular stress response in obesity-associated retinal degeneration","volume":"679","author":"Godisela","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2024.110161_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106326","article-title":"Polyol pathway and redox balance in diabetes","volume":"182","author":"Garg","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.abb.2024.110161_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ahj.2022.11.003","article-title":"Rationale and design of the aldose reductase inhibition for stabilization of exercise capacity in heart failure trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy","volume":"256","author":"Januzzi","year":"2023","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-023-01811-w","article-title":"Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation","volume":"22","author":"Gopal","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.abb.2024.110161_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.636267","article-title":"Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications","volume":"12","author":"Jannapureddy","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.surg.2012.09.017","article-title":"Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia\/reperfusion via aldose reductase","volume":"153","author":"Wen","year":"2013","journal-title":"Surgery"},{"issue":"13","key":"10.1016\/j.abb.2024.110161_bib21","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1021\/acs.jmedchem.2c00380","article-title":"Novel hydroxychalcone-based dual inhibitors of aldose reductase and \u03b1-glucosidase as potential therapeutic agents against diabetes mellitus and its complications","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.abb.2024.110161_bib22","doi-asserted-by":"crossref","first-page":"11747","DOI":"10.1021\/acs.jafc.0c05102","article-title":"Aldose reductase inhibitor engeletin suppresses pelvic inflammatory disease by blocking the Phospholipase C\/protein kinase C-dependent\/NF-\u03baB and MAPK cascades","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.abb.2024.110161_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000118","article-title":"Determination of the inhibition profiles of pyrazolyl\u2013thiazole derivatives against aldose reductase and \u03b1-glycosidase and molecular docking studies","volume":"353","author":"Demir","year":"2020","journal-title":"Arch. Pharmazie"},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41401-021-00788-0","article-title":"Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity","volume":"43","author":"He","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.abb.2024.110161_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121224","article-title":"Hyperandrogen-induced polyol pathway flux increase affects ovarian function in polycystic ovary syndrome via excessive oxidative stress","volume":"313","author":"Wang","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/acsomega.0c05102","article-title":"(\u2212)-Kusunokinin as a potential aldose reductase inhibitor: equivalency observed via AKR1B1 dynamics simulation","volume":"6","author":"Tanawattanasuntorn","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.abb.2024.110161_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175191","article-title":"Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer","volume":"931","author":"Bailly","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100974","article-title":"AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma","volume":"6","author":"Syamprasad","year":"2024","journal-title":"JHEP Reports"},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-022-00711-9","article-title":"Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis","volume":"5","author":"Oaks","year":"2023","journal-title":"Nat. Metab."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib30","article-title":"Phosphoproteome of signaling by ErbB2 in ovarian cancer cells","volume":"1870","author":"Sidhanth","year":"2022","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"issue":"15","key":"10.1016\/j.abb.2024.110161_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115575","article-title":"Design synthesis and evaluation of novel aldose reductase inhibitors: the case of indolyl\u2013sulfonyl\u2013phenols","volume":"28","author":"Koutsopoulos","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.abb.2024.110161_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.abb.2017.01.007","article-title":"Interaction of AR and iNOS in lens epithelial cell: a new pathogenesis and potential therapeutic targets of diabetic cataract","volume":"615","author":"Li","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2024.110161_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.abb.2018.07.009","article-title":"Regulation of aldose reductase activity by tubulin and phenolic acid derivates","volume":"654","author":"Rivelli","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.abb.2024.110161_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm500907a","article-title":"Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions","volume":"58","author":"Maccari","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110161_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112742","article-title":"Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus","volume":"207","author":"Kousaxidis","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.abb.2024.110161_bib36","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bmc.2019.03.015","article-title":"Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors","volume":"27","author":"Ji","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.abb.2024.110161_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21935","article-title":"Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney","volume":"31","author":"Demir","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"24","key":"10.1016\/j.abb.2024.110161_bib38","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1016\/j.bmcl.2011.10.035","article-title":"Structure\u2013activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors","volume":"21","author":"Fatmawati","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"23","key":"10.1016\/j.abb.2024.110161_bib39","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.3390\/molecules25235491","article-title":"Medicinal potential of isoflavonoids: polyphenols that may cure diabetes","volume":"25","author":"Ahmed","year":"2020","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.abb.2024.110161_bib40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4155\/fmc-2020-0032","article-title":"Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications","volume":"12","author":"Kumar","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.abb.2024.110161_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104556","article-title":"QM\/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy","volume":"108","author":"Choudhary","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.abb.2024.110161_bib42","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1021\/acs.jmedchem.9b00359","article-title":"Overview of recent strategic advances in medicinal chemistry","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2165\/00003495-199958040-00010","article-title":"Gatifloxacin","volume":"58","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.abb.2024.110161_bib44","series-title":"Profiles of Drug Substances, Excipients and Related Methodology","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.podrm.2017.02.004","article-title":"Chapter four - lomefloxacin","author":"Al-Wabli","year":"2017"},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/07391102.2020.1711808","article-title":"Investigating the mechanism of binding of nalidixic acid with deoxyribonucleic acid and serum albumin: a biophysical and molecular docking approaches","volume":"39","author":"Siddiqui","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110161_bib46","series-title":"Analytical Profiles of Drug Substances","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0099-5428(08)60540-7","article-title":"Norfloxacin","author":"Mazuel","year":"1991"},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0149-2918(00)89007-4","article-title":"Sparfloxacin: a review","volume":"22","author":"Schentag","year":"2000","journal-title":"Clin. Therapeut."},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ddr.22031","article-title":"Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors","volume":"84","author":"Tokal\u0131","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.abb.2024.110161_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204350","article-title":"Exploration of Some Bis-Sulfide and Bis-Sulfone Derivatives as Non-Classical Aldose Reductase \u0130nhibitors","volume":"8","author":"T\u00fcrke\u015f","year":"2023","journal-title":"ChemistrySelect"},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib50","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11030-022-10526-1","article-title":"Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors","volume":"27","author":"Demir","year":"2023","journal-title":"Mol. Divers."},{"issue":"2","key":"10.1016\/j.abb.2024.110161_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12010-019-03099-7","article-title":"The influence of some nonsteroidal anti-inflammatory drugs on metabolic enzymes of aldose reductase, sorbitol dehydrogenase, and \u03b1-glycosidase: a perspective for metabolic disorders","volume":"190","author":"Demir","year":"2020","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/13813455.2020.1742166","article-title":"Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes","volume":"128","author":"Demir","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"5259","key":"10.1016\/j.abb.2024.110161_bib54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.abb.2024.110161_bib55","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/jm00161a033","article-title":"Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids","volume":"29","author":"Cerelli","year":"1986","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200570","article-title":"A new series of hydrazones as small-molecule aldose reductase inhibitors","volume":"356","author":"Alt\u0131ntop","year":"2023","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.abb.2024.110161_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107221","article-title":"Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: bioactivity, cytotoxicity, and molecular modeling studies","volume":"145","author":"G\u00fcle\u00e7","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"22","key":"10.1016\/j.abb.2024.110161_bib58","doi-asserted-by":"crossref","first-page":"12008","DOI":"10.1080\/07391102.2021.1967195","article-title":"Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes","volume":"40","author":"Demir","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.abb.2024.110161_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2991","article-title":"N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors","volume":"35","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Mol. Recogn."},{"issue":"3","key":"10.1016\/j.abb.2024.110161_bib60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.abb.2024.110161_bib61","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.febslet.2013.09.031","article-title":"Inhibitor selectivity between aldo\u2013keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111)","volume":"587","author":"Zhang","year":"2013","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.abb.2024.110161_bib62","series-title":"Schr\u00f6dinger Release 2024-2: Protein Preparation Wizard","year":"2024"},{"key":"10.1016\/j.abb.2024.110161_bib63","series-title":"Schr\u00f6dinger Release 2024-2","year":"2024"},{"issue":"12","key":"10.1016\/j.abb.2024.110161_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKaprediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.abb.2024.110161_bib65","series-title":"Schr\u00f6dinger Release 2024-2","year":"2024"},{"issue":"12","key":"10.1016\/j.abb.2024.110161_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3063","article-title":"Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico","volume":"36","author":"T\u00fcrke\u015f","year":"2023","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.abb.2024.110161_bib67","series-title":"Schr\u00f6dinger Release 2024-2: Glide","year":"2024"},{"issue":"3","key":"10.1016\/j.abb.2024.110161_bib68","first-page":"586","article-title":"Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3)-one derivatives as potential aldose reductase inhibitors","volume":"83","author":"Tokal\u0131","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.abb.2024.110161_bib69","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.abb.2024.110161_bib70","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110161_bib71","series-title":"Schr\u00f6dinger Release 2024-2: Receptor Grid Generation","year":"2024"},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1515\/chem-2021-0032","article-title":"A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity","volume":"19","author":"Sever","year":"2021","journal-title":"Open Chem."},{"key":"10.1016\/j.abb.2024.110161_bib73","series-title":"Schr\u00f6dinger Release 2024-2","year":"2024"},{"key":"10.1016\/j.abb.2024.110161_bib74","series-title":"Schr\u00f6dinger Release 2024-2: Prime","year":"2024"},{"issue":"6","key":"10.1016\/j.abb.2024.110161_bib75","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/ci700271z","article-title":"Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB\/SA scoring","volume":"47","author":"Barreiro","year":"2007","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","article-title":"The fluoroquinolone antibacterials: past, present and future perspectives","volume":"16","author":"Appelbaum","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"TOPIC T1","key":"10.1016\/j.abb.2024.110161_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.jac.a020889","article-title":"Quinolone generations: natural history or natural selection?","volume":"46","author":"Ball","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.abb.2024.110161_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1562\/0031-8655(2000)071<0281:SPOFAA>2.0.CO;2","article-title":"Spectroscopic properties of fluoroquinolone antibiotics and nanosecond solvation dynamics in aerosol-OT reverse micelles","volume":"71","author":"Park","year":"2000","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.abb.2024.110161_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105473","article-title":"Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase","volume":"117","author":"Yapar","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib81","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12010-019-03009-x","article-title":"Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity","volume":"189","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"5","key":"10.1016\/j.abb.2024.110161_bib82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0969-2126(97)00216-5","article-title":"A \u2018specificity\u2019 pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil","volume":"5","author":"Urzhumtsev","year":"1997","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.abb.2024.110161_bib83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/prot.20021","article-title":"Probing flexibility and \u201cinduced\u2010fit\u201d phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations, Proteins: structure","volume":"56","author":"Sotriffer","year":"2004","journal-title":"Function, and Bioinformatics"},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib84","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/prot.20057","article-title":"Virtual screening for inhibitors of human aldose reductase","volume":"55","author":"Kraemer","year":"2004","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"21","key":"10.1016\/j.abb.2024.110161_bib85","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1073\/pnas.90.21.9847","article-title":"Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat","volume":"90","author":"Wilson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.abb.2024.110161_bib86","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/prot.20001","article-title":"Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors","volume":"55","author":"El\u2010Kabbani","year":"2004","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"5","key":"10.1016\/j.abb.2024.110161_bib87","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jmb.2008.03.063","article-title":"Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features","volume":"379","author":"Steuber","year":"2008","journal-title":"J. Mol. Biol."}],"updated-by":[{"DOI":"10.1016\/j.abb.2024.110211","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T20:00:47Z","timestamp":1745611247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":87,"alternative-id":["S0003986124002832"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110161","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.abb.2024.110211","asserted-by":"object"}]},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110161"}}